Conjunctival UVAF photography is reliable and valid

Article

Conjunctival ultraviolet autofluorescence (UVAF) photography is valid and reliable for detecting pre-clinical sunlight-induced UV damage

Conjunctival ultraviolet autofluorescence (UVAF) photography is valid and reliable for detecting pre-clinical sunlight-induced UV damage, states a paper in the British Journal of Ophthalmology.

A team led by Professor David A Mackey, Lions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Australia, studied 599 people in the cross-sectional Norfolk Island Eye Study.

In total, the team used 196 UVAF photographs of 49 patients for intra-observer reliability assessment and 60 UVAF photographs of 15 people for inter-reliability assessment from the Norfolk Island Eye Study.

UV photography was used to measure conjunctival UVAF and UVAF area was calculated by computerized methods. A UV questionnaire was used to measure outdoor activity during summer and winter.

Both intra-observer and inter-observer concordance correlation coefficients of total UVAF surpassed 0.900. According to the questionnaire results, increased time spent outdoors strongly correlated with a rise in total UVAF in summer and winter.

It was found that the intra- and inter-observer reliability of conjunctival UVAF is significantly high. UVAF is strongly linked to the amount of time a ptient spends outdoors.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.